Applications of 2D descriptors in drug design: a DRAGON tale.
about
Advances in computationally modeling human oral bioavailabilityParadigm shift in toxicity testing and modeling.Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors.Advances in computational methods to predict the biological activity of compounds.Computational ligand-based rational design: Role of conformational sampling and force fields in model development.Experimental and computational studies of fatty acid distribution networks.A comparative study of SMILES-based compound similarity functions for drug-target interaction predictionModel for vaccine design by prediction of B-epitopes of IEDB given perturbations in peptide sequence, in vivo process, experimental techniques, and source or host organismsAdvances in quantitative structure-activity relationship models of antioxidants.Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.Latest QSAR study of adenosine A[Formula: see text] receptor affinity of xanthines and deazaxanthines.Chiral Brønsted Acid-Catalyzed Enantioselective α-Amidoalkylation Reactions: A Joint Experimental and Predictive Study.2D-Qsar for 450 types of amino acid induction peptides with a novel substructure pair descriptor having wider scope.Predictive chemometric modeling of DPPH free radical-scavenging activity of azole derivatives using 2D- and 3D-quantitative structure-activity relationship tools.Predictive Modeling of Antioxidant Coumarin Derivatives Using Multiple Approaches: Descriptor-Based QSAR, 3D-Pharmacophore Mapping, and HQSAR.Estimating sensory irritation potency of volatile organic chemicals using QSARs based on decision tree methods for regulatory purpose.Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates.Chemometric QSAR modeling and in silico design of antioxidant NO donor phenols.A quantitative structure-activity relationship study on serotonin 5-HT6) receptor ligands: indolyl and piperidinyl sulphonamides.SCRAMBLE'N'GAMBLE: a tool for fast and facile generation of random data for statistical evaluation of QSAR models.Computer-aided drug design applied to Parkinson targets.The Need for, and the Role of the Toxicological Chemist in the Design of Safer Chemicals.QSAR studies on N-aryl derivative activity towards Alzheimer's disease.Models for anti-tumor activity of bisphosphonates using refined topochemical descriptors.The Calculation of Molecular Structural Similarity: Principles and Practice.In Silico ADME/Tox PredictionsApplication of ligand- and receptor-based approaches for prediction of the HIV-RT inhibitory activity of fullerene derivativesScaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation
P2860
Q27008316-0A2171C0-3781-46EA-A42E-4D6A47E57AF7Q30455359-8A5FE0F6-20DE-4FA1-9624-80B86D0905F2Q34193117-C03E8B95-B79A-48D0-B930-842D9412A521Q34289760-4E366E68-734A-41DD-8756-D89837805789Q35069159-0D074AC3-7D84-4C66-AC97-459B6B53022AQ35748105-040D3FDF-8EBA-4B2D-8821-0CBC4E9DB6A8Q35961494-A43070D2-A49A-4FC8-85A3-F9F9D1F2D3B0Q37704956-56ED4FF2-90E9-4F51-B837-A4D0C206B0B8Q38088335-69A34B5A-39B7-4778-A61B-BB26B0647E64Q38469746-4D49B929-DEE3-4184-A38E-75B2645990B4Q38986357-EF637678-8FFE-4F34-AD4B-690A85831028Q39339733-0D44A73C-4732-4BA3-ADF3-67AB49BF4078Q39415708-F70D58BD-7245-452E-A546-E9A08FAC1B28Q39456587-945CDA47-DD1C-4DE6-88A5-707147A6CE05Q39625302-EF32E66E-335D-457D-8C01-E73A2B0C3475Q41365161-B63E0155-9C1D-469C-92C4-DD7BB80EF353Q42043842-5C3EF9F2-F6F2-46DA-80E2-D807049E4107Q42083463-E4863C40-41E4-4DE1-9838-E4A2ADB385B2Q43026448-9E1CC9AC-7C62-45D1-8DAF-14CF5DF0BD6AQ47101590-108E8DB3-FA0B-4C8B-B49B-D8DF4794FDB7Q47658773-EA5AFA52-8084-4CFA-B4EF-023FD25622EFQ50065411-76B357F6-7770-4E6B-9CA6-DC3AD2DE151CQ51838343-45325216-A2EA-4B17-BB1C-B2BBCF390037Q53743085-FA28C5B4-BD8D-4969-A537-D775B54472CAQ53787277-5BC9463A-EED3-41EE-A5FC-CA1D965C480DQ56984194-63291E2E-E1A0-4A33-927E-934D2517C98CQ56999511-D4536F4C-85F4-4575-93D8-A7392D6AD17DQ58602715-2A3BD841-9C75-4B5C-A186-592A2E3E9DA0
P2860
Applications of 2D descriptors in drug design: a DRAGON tale.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Applications of 2D descriptors in drug design: a DRAGON tale.
@ast
Applications of 2D descriptors in drug design: a DRAGON tale.
@en
type
label
Applications of 2D descriptors in drug design: a DRAGON tale.
@ast
Applications of 2D descriptors in drug design: a DRAGON tale.
@en
prefLabel
Applications of 2D descriptors in drug design: a DRAGON tale.
@ast
Applications of 2D descriptors in drug design: a DRAGON tale.
@en
P2093
P1476
Applications of 2D descriptors in drug design: a DRAGON tale.
@en
P2093
M Natália D S Cordeiro
Maykel Pérez González
Robert D Combes
P304
P356
10.2174/156802608786786598
P577
2008-01-01T00:00:00Z